Valsartan tablets recalled over foreign material
- Recall date
- July 16, 2018
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Major Pharmaceuticals recalls Major Pharmaceuticals — Valsartan tablets, 80mg USP and 160 mg USP
- Brand / firm
- Major Pharmaceuticals, Major Pharmaceuticals
Why it was recalled
may contain the probable carcinogen Nnitrosodimethylamine (NDMA) — Potential Foreign Material
What was recalled
Valsartan tablets, 80mg USP and 160 mg USP
Read the official recall notice →
Get recall alerts
Free email alert whenever Major Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Major Pharmaceuticals, Major Pharmaceuticals